|
| Press Releases |
|
 |
|
| Tuesday, August 29, 2023 |
|
|
Everbright Grand China Announces 2023 Interim Results |
| Everbright Grand China Assets Limited ("Everbright Grand China" or the "Group"; HKEX stock code: 03699), a subsidiary of China Everbright Group, principally engaged in the businesses of property leasing, property management and the sales of properties held for sale, announced its interim results for the six months ended 30 June 2023 ("Reporting Period"). more info >> |
|
| Tuesday, March 28, 2023 |
|
|
光大永年公布2022年全年业绩 |
光大永年有限公司，为中国光大集团旗下物业租赁、物业管理及销售持作出售物业公司（「光大永年」或「集团」，香港联交所股份代号：3699）今天公布截至2022年12月31日止年度（「回顾年度」）之全年业绩。
more info >> |
|
|
光大永年公佈2022年全年業績 |
| 光大永年有限公司，為中國光大集團旗下物業租賃、物業管理及銷售持作出售物業公司（「光大永年」或「集團」，香港聯交所股份代號：3699）今天公佈截至2022年12月31日止年度（「回顧年度」）之全年業績。 more info >> |
|
|
Everbright Grand China Announces 2022 Annual Results |
| Everbright Grand China Assets Limited ("Everbright Grand China" or the "Group"; HKEX stock code: 3699), a subsidiary of China Everbright Group, principally engaged in the businesses of property leasing, property management and sales of properties held for sale, announced its annual results ended 31 December 2022 ("Reporting Period"). more info >> |
|
| Thursday, August 25, 2022 |
|
|
光大永年上半年物業租賃收入穩步增加 |
| 光大永年有限公司，為中國光大集團旗下物業租賃、及物業管理及銷售持作出售物業公司（「光大永年」或「集團」，香港聯交所股份代號：03699）今天公佈截至2022年6月30日止半年度（「報告期內」）之中期業績。 more info >> |
|
|
光大永年上半年物业租赁收入稳步增加 |
| 光大永年有限公司，为中国光大集团旗下物业租赁、及物业管理及销售持作出售物业公司（「光大永年」或「集团」，香港联交所股份代号：03699）今天公布截至2022年6月30日止半年度（「报告期内」）之中期业绩。 more info >> |
|
|
Everbright Grand China's Property Rental Income has Steadily Increased in the first half of 2022 |
| Everbright Grand China Assets Limited ("Everbright Grand China" or the "Group"; HKEX stock code: 03699), a subsidiary of China Everbright Group, principally engaged in the businesses of property leasing, property management and the sales of properties held for sale, announced its interim results for the six months ended 30 June 2022 ("Reporting Period"). more info >> |
|
| Thursday, March 25, 2021 |
|
|
光大永年公布2020年全年业绩 |
| 光大永年有限公司，为中国光大集团旗下物业租赁、物业管理及销售持作出售物业公司（「光大永年」或「集团」，香港联交所股份代号：03699）今天公布截至2020年12月31日止年度（「回顾年度」）之全年业绩。 more info >> |
|
|
光大永年公佈2020年全年業績 |
光大永年有限公司，為中國光大集團旗下物業租賃、物業管理及銷售持作出售物業公司（「光大永年」或「集團」，香港聯交所股份代號：03699）今天公佈截至2020年12月31日止年度（「回顧年度」）之全年業績。
more info >> |
|
|
Everbright Grand China Announces 2020 Annual Results |
| Everbright Grand China Assets Limited ("Everbright Grand China" or the "Group"; HKEX stock code: 03699), a subsidiary of China Everbright Group, principally engaged in the businesses of property leasing, property management and sales of properties held for sale, announced its annual results ended 31 December 2020 ("Reporting Period"). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TOYOTA、ハイエース（バン・ワゴン・コミューター）を一部改良
Jan 13, 2026 13:50: JST
|
|
|
Honda四輪事業のシンボルに新たな「Hマーク」を採用
Jan 13, 2026 13:50: JST
|
|
|
'Power Women' shaping Asia's tomorrow's cities honoured at ARES 2025 VIP celebration
Jan 13, 2026 12:00 HKT/SGT
|
|
|
Australia Developers Triumph at the 20th PropertyGuru Asia Property Awards Grand Final
Jan 13, 2026 12:00 HKT/SGT
|
|
|
Assembly Unifies APAC Network Under One Brand to Build Asia's Leading Tech-Powered Brand Performance Agency
Jan 13, 2026 11:00: JST
|
|
|
アセンブリー、アジア太平洋地域ネットワークを単一ブランドに統合し、アジアを代表するテクノロジー駆動型ブランドパフォーマンスエージェンシーを構築
Jan 13, 2026 11:00: JST
|
|
|
Assembly Unifies APAC Network Under One Brand to Build Asia's Leading Tech-Powered Brand Performance Agency
Jan 13, 2026 10:00 HKT/SGT
|
|
|
Eisai and Nuvation Bio Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside the U.S., China and Japan
Jan 13, 2026 9:50 JST
|
|
|
德國透過北約支援與採購局採購八架MQ-9B海衛士(R)無人機
Jan 13, 2026 07:00 HKT/SGT
|
|
|
德国通过北约支持与采购局采购八架MQ-9B海卫士无人机
Jan 13, 2026 07:00 HKT/SGT
|
|
|
Germany Buys Eight MQ-9B SeaGuardian(R) RPA Through NSPA
Jan 13, 2026 07:00 HKT/SGT
|
|
|
OBIファーマとTegMine Therapeutics、糖鎖標的ADCに関する独占的グローバルライセンス契約を締結
Jan 12, 2026 21:00: JST
|
|
|
浩鼎與 TegMine Therapeutics簽訂醣標靶ADC 全球商業授權合約
Jan 12, 2026 20:00 HKT/SGT
|
|
|
浩鼎与 TegMine Therapeutics 签订醣靶标 ADC 全球商业授权合约
Jan 12, 2026 20:00 HKT/SGT
|
|
|
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Jan 12, 2026 20:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
